BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24694470)

  • 1. Therapies in patients with IgA nephropathy.
    Tsuboi N; Kawamura T
    Intern Med; 2014; 53(7):649-50. PubMed ID: 24694470
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunotherapy of primary glomerulonephritis].
    Ritz E; Mickisch O
    Internist (Berl); 1989 Mar; 30(3):180-95. PubMed ID: 2654060
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressive therapy in patients with IgA nephropathy.
    Peters HP; van den Brand JA; Berger SP; Wetzels JF
    Neth J Med; 2015 Jul; 73(6):284-9. PubMed ID: 26228193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression in IgA nephropathy: how certain are we?
    Floege J; Rauen T
    Kidney Int; 2016 Jan; 89(1):9-11. PubMed ID: 26759037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of IgA nephropathy: status at the end of the millenium.
    Glassock RJ
    J Nephrol; 1999; 12(5):288-96. PubMed ID: 10630691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of patients with IgA-nephropathy: a critical appraisal.
    Floege J; Mertens P
    Kidney Blood Press Res; 2000; 23(3-5):207-9. PubMed ID: 11031723
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapy in IgA nephropathy.
    Clarkson AR; Woodroffe AJ; Bannister KM; Odum J; Thomas A
    Contrib Nephrol; 1993; 104():189-97. PubMed ID: 8325029
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasmapheresis in the treatment of IgA nephropathy.
    Macanović M; Golemac S; Macanović K; Hadzijahić H; Verbić D
    Przegl Lek; 1985; 42(3):355-7. PubMed ID: 4048517
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment tentatives in IgA nephropathy.
    Clarkson AR; Woodroffe AJ
    Semin Nephrol; 1987 Dec; 7(4):393-8. PubMed ID: 3127870
    [No Abstract]   [Full Text] [Related]  

  • 10. Update on immunosuppressive therapy in human and experimental glomerulonephritis.
    Jacquot C; Baran D; Vendeville B; Pelletier L; Druet P
    Adv Nephrol Necker Hosp; 1988; 17():77-99. PubMed ID: 3124553
    [No Abstract]   [Full Text] [Related]  

  • 11. [IgA nephropathy - prognostic factors and treatment].
    Wieliczko M; Dylewska M
    Wiad Lek; 2016; 69(5):707-710. PubMed ID: 28033590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [IgA-nephropathy: the most common type of glomerulonephritis].
    Mertens PR; Floege J
    Dtsch Med Wochenschr; 2003 May; 128(22):1242-6. PubMed ID: 12772083
    [No Abstract]   [Full Text] [Related]  

  • 13. Addition of immunosuppression to comprehensive supportive care did not benefit patients with IgA nephropathy.
    Lalayiannis AD; Lalayiannis AD
    Arch Dis Child Educ Pract Ed; 2017 Feb; 102(1):56. PubMed ID: 27609604
    [No Abstract]   [Full Text] [Related]  

  • 14. Con: STOP immunosuppression in IgA nephropathy.
    Rauen T; Eitner F; Fitzner C; Floege J
    Nephrol Dial Transplant; 2016 Nov; 31(11):1771-1774. PubMed ID: 27515693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasculitic IgA nephropathy: prognosis and outcome.
    Pankhurst T; Lepenies J; Nightingale P; Howie AJ; Adu D; Harper L
    Nephron Clin Pract; 2009; 112(1):c16-24. PubMed ID: 19342865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bortezomib-based antibody-mediated rejection therapy and simultaneous conversion to belatacept.
    Krisl JC; Alloway RR; Shields AR; Cardi MA; Woodle ES
    Transplantation; 2014 Feb; 97(4):e30-2. PubMed ID: 24531826
    [No Abstract]   [Full Text] [Related]  

  • 17. IgA nephropathy and pulmonary hemorrhage in an adult.
    Fung M; Churchill D; Alexopoulou I; Ingram A
    Am J Nephrol; 2001; 21(4):318-22. PubMed ID: 11509805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse alveolar hemorrhage in IgA nephropathy: case series and systematic review of the literature.
    Rajagopala S; Parameswaran S; Ajmera JS; Ganesh RN; Katrevula A
    Int J Rheum Dis; 2017 Jan; 20(1):109-121. PubMed ID: 26845236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive treatments for immunoglobulin A nephropathy: a meta-analysis of randomized controlled trials.
    Samuels JA; Strippoli GF; Craig JC; Schena FP; Molony DA
    Nephrology (Carlton); 2004 Aug; 9(4):177-85. PubMed ID: 15363047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on the treatment of IgA nephropathy.
    Barbour S; Feehally J
    Curr Opin Nephrol Hypertens; 2017 Jul; 26(4):319-326. PubMed ID: 28399021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.